Search Results for ''

published presentations and documents on DocSlides.

BRCA1 and BRCA2 Full Gene Sequence Analysis and Common DeletionDuplic

BRCA1 and BRCA2 Full Gene Sequence Analysis and Common DeletionDuplic

by beatrice

Testing includes full gene sequencing of exons and...

Overview of BRCA1 and

Overview of BRCA1 and

by ashley

BRCA2. What we know so far. Dr Helen Hanson and Dr...

NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity

NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity

by skylar

Laura Cortesi. BRCA1/2 Mutations: Cancer Risks. BR...

Interaction-based Learning in Genomics

Interaction-based Learning in Genomics

by lindy-dunigan

...

by phoebe-click

damage repair; good or bad for . . . ca...

Genetic testing for breast cancer

Genetic testing for breast cancer

by faustina-dinatale

Susan M. Domchek, MD. Basser Professor of Oncolog...

by yoshiko-marsland

. Inheritance. . Review. . Incomplete. . Inhe...

Measurement of Recurrence in Human TNBC cell Culture containing the BRCA1 Gene

Measurement of Recurrence in Human TNBC cell Culture containing the BRCA1 Gene

by myesha-ticknor

Preksha Jerajani. BNFO 300. Triple Negative Breas...

by adhesivedisney

........................... ..... .. .............

DNA damage repair; good or bad for

DNA damage repair; good or bad for

by ximena

. . cancer . development and treatment. Ka...

Genetic Testing for BRCA1 and BRCA2 Inform

Genetic Testing for BRCA1 and BRCA2 Inform

by barbara

How common are BRCA1 and BRCA2 mutations in the ge...

Breast Cancer Risk: Genes

Breast Cancer Risk: Genes

by victoria

and the . Environment. Note: You will need to prov...

Module 2: Measuring gene expression

Module 2: Measuring gene expression

by bikershomemaker

BRCA2 and pathway dependency. 4/5/. 18. First, let...

by ellena-manuel

Review . September 17, 2012. Ashkan Afshin, MD, M...

Breast & Ovarian Cancer:

Breast & Ovarian Cancer:

by debby-jeon

BRCA1 and BRCA2. Jennifer . Hardee. Normal functi...

Patient Selection for PARP

Patient Selection for PARP

by sherrill-nordquist

Inhibitors:. Purpose and Practicalities . Present...

Novel Strategies in the Management of Progressive

Novel Strategies in the Management of Progressive

by calandra-battersby

BRCA. -Mutated Breast Cancer. This program will i...

Breast & Ovarian Cancer:

Breast & Ovarian Cancer:

by faustina-dinatale

BRCA1 and BRCA2. Jennifer . Hardee. Normal functi...

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

by lois-ondreau

Ben Ho Park MD PhD. Johns Hopkins University. Fin...

Neoadjuvant Therapy for

Neoadjuvant Therapy for

by celsa-spraggs

Triple Negative Breast Cancer. Steven J. Isakoff,...

Medical Genomics Promise, Peril and Price.

Medical Genomics Promise, Peril and Price.

by marina-yarberry

Alison J Whelan M.D., FACP. Professor of Medicine...

Breast Cancer Risk Assessment & Prevention Strategies

Breast Cancer Risk Assessment & Prevention Strategies

by danika-pritchard

Generosa. . Grana. , MD. Professor, Cooper Medic...

Heredity Tidbit

Heredity Tidbit

by lindy-dunigan

Participants: Facilitator:. Virginia . Carson ...

Update on genetic testing for hereditary breast cancer synd

Update on genetic testing for hereditary breast cancer synd

by celsa-spraggs

Kristin . DePrince. Mattie, M.S.. Licensed / Cer...

Cancer Genetic Risk Assessment

Cancer Genetic Risk Assessment

by olivia-moreira

James Ford, MD and Nicki Chun, . MS, . LCGC. Canc...

Hereditary cancer, the next generation

Hereditary cancer, the next generation

by yoshiko-marsland

Raymond Kim. MD/PhD, FRCPC, FCCMG, FACMG. Medical...

by myesha-ticknor

Talking point:. Genetics of ovarian cancer. 49F. ...

http://2.bp.blogspot.com/-Ni0GZUo4_WY/UI_wlyATFXI/AAA

http://2.bp.blogspot.com/-Ni0GZUo4_WY/UI_wlyATFXI/AAA

by cheryl-pisano

AAAAADMw/z-P-qGQqskQ/s640/. RedLightGreenLight1. ...

Bayesian Factor Modelling for

Bayesian Factor Modelling for

by lois-ondreau

Omics. Data Analysis to Drug Treatments. Naruemo...

The genetic epidemiology of common hormonal

The genetic epidemiology of common hormonal

by lindy-dunigan

cancers. Deborah Thompson. Centre for Cancer Gene...

variantslinkingfunctionalimpacttocancerriskRickACMBoonenMaaikePG

variantslinkingfunctionalimpacttocancerriskRickACMBoonenMaaikePG

by evans

Protein-truncatingvariantsinthebreastcancersuscept...

Genetic Patterns of Ashkenazi Jews

Genetic Patterns of Ashkenazi Jews

by priscilla

Victoria Olson. Ashkenazi Jews. A subculture of Ju...

Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer

Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer

by isabella2

Gavin Buckley. Supervisor: . Dr.. Malgorzata . Kr...

Year in Review Prostate Cancer

Year in Review Prostate Cancer

by faith

Emmanuel . S . Antonarakis. , MD. Professor of Onc...

Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi

Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi

by williams

Foundation Medicine. ctDNA. is good information f...

Why and how to test for germline

Why and how to test for germline

by isabella2

BRCA. mutations in Pancreatic Cancer. ESDO Learni...

GU CONNECT animated video

GU CONNECT animated video

by sophie

Clinical implementation of testing and PARP. i. m...

BIOLOGY OF CANCER Cancer

BIOLOGY OF CANCER Cancer

by kimberly

is disease characterized by uncontrolled cell grow...

Ovarian cancer Talking point:

Ovarian cancer Talking point:

by audrey

Genetics of ovarian cancer. 49F. Underwent risk-re...

e110 VOL 130 NO 3 SEPTEMBER 2017 OBSTETRICS GYNECOLOGY

e110 VOL 130 NO 3 SEPTEMBER 2017 OBSTETRICS GYNECOLOGY

by finley

tiple family members with breast cancer, ovarian c...